2018 International Chordoma Research Workshop
Thursday, March 22 – Friday, March 23 • Boston, MA
Boston Marriott Cambridge Hotel
Registration is now open for the sixth International Chordoma Research Workshop. We invite you to join us to exchange new data and ideas with colleagues from around the world, and help shape the future of chordoma research and treatment development.
About the Workshop
Since 2007, the International Chordoma Research Workshop (ICRW) series has served as the focal point and principal gathering of the worldwide chordoma research community.
Designed to catalyze meaningful research advances, the workshop is:
- Participatory: more than just an opportunity to learn about new research advances, each session is designed to facilitate discussion and debate among participants, and to elicit new ideas that can move the field forward
- Multidisciplinary: with topics ranging from basic biology to clinical research, the workshop attracts a diverse mix of participants who bring a wide range of complementary expertise and perspectives to the conversation
- Action-oriented: beyond just serving as a venue for information exchange, the purpose of the workshop is to surface critical questions, identify new research opportunities, and collectively define priorities for the field
The 2018 ICRW will consist of a mix of plenary presentations, group discussions, and breakout sessions focusing on topics ranging from chordoma biology to clinical research. Additionally, it will feature a poster session and two evening receptions, providing multiple opportunities to network with colleagues. It will conclude on Friday evening with a special dinner including members of the chordoma patient community celebrating 10 years of progress since the launch of the Chordoma Foundation.
- David Drewry, PhD – University of North Carolina
- Chris Heery, MD – Bavarian Nordic
- Charles Lin, PhD – Baylor College of Medicine
- Erin McKean, MD – University of Michigan
- Deric Park, MD – National Cancer Institute
- Shreyas Patel, MD – MD Anderson Cancer Cancer Center
- Rob Schoelkopf, PhD – Yale
- Joe Schwab, MD – Massachusetts General Hospital
- Brigitte Widemann, MD – National Cancer Institute